Altered vascular function in early stages of heart failure in hamsters

Journal of Cardiac Failure

Volumn 3, Issue 4, 1997, Pages 311-318

  Crespo, Maria J ^a   Altieri, Pablo I ^a   Escobales, Nelson ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Acetylcholine; Angiotensin II; Angiotensin converting enzyme; Endothelial dysfunction; Indomethacin; Syrian hamsters; Vascular tone

Indexed keywords

INDOMETACIN; NORADRENALIN; VASOCONSTRICTOR AGENT;

ANIMAL; AORTA; ARTICLE; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG EFFECT; HAMSTER; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYRIAN HAMSTER; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; AORTA; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; INDOMETHACIN; MALE; MESOCRICETUS; NOREPINEPHRINE; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031297255     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90031-2     Document Type: Article

References (39)

1. Zelis R, Flaim SF: Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:432-459
2. Brozema S, Jessup M: Pathophysiologic strategies in the management of congestive heart failure. Annu Rev Med 1990;41:65-74
3. Packer M: Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting enzyme inhibition. Am J Cardiol 1987;60:179-184
4. Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML: Diverse biological action of atrial natriuretic peptide. Physiol Rev 1990;70:665-669
5. Tan L-B, Jalil JE, Janicki JS, Weber KT: Cardiotoxic affects of angiotensin II. J Am Coll Cardiol 1989;13 (suppl.):12A-18A
6. Teerlink JR, Clozel M, Fischli M, Clozel JP: Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 1993;22:615-620
7. Lindsay DC, Jiang C, Brunotte F, Adamopoulos S, Coats AJ, Rajagopalan B, Poole-Wilson PA, Collins P: Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 1992;26:694-697
8. Katz SD, Schwarz M, Yuen J, Le Jemtel TH: Impaired Ach-mediated vasodilation in patients with congestive heart failure. Circulation 1993;88:55-61
9. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MG, Alexander RW: Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-779
10. Angus JA, Ferrier CP, Sudhir K, Kaye DM, Jennings GL: Impaired contraction and relaxation in skin resistance from patients with congestive heart failure. Cardiovasc Res 1993;27:204-210
11. Katz SD, Biassuci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, Le Jemtel TH: Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Cardiol 1992;19:918-925
12. Kaiser L, Spickard RC, Olivier B: Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-H967
13. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifrtz SM: Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-1596
14. Drexler H, Lu W: Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol 1992;262:H1640-1645
15. Factor SM, Sonnenblick EH: Hypothesis: is congestive cardiomyopathy caused by hyperreactive myocardial microcirculation (microvascular spasm)? Am J Cardiol 1982;50: 1149-1152
16. Conway RS, Natelson BH, Chen WH, Ting W: Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular hypothesis. Cardiovasc Res 1994;28:320-324
17. Bank AJ, Rector TS, Tschumperlin LK, Kraemer MD, Letourneau JG, Kubo SH: Endothelium-dependent vasodilation of peripheral conduit arteries in patients with heart failure. J Card Fail 1994;1:35-43
18. Main JS, Foster C, Armstrong PW: Inhibitory role of the coronary arterial endothelium to alpha-adrenergic stimulation in experimental heart failure. Circ Res 1991;68:940-946
19. Treasure CB, Alexander W: The dysfunctional endothelium in heart failure. J Am Coll Cardiol 1993;22(suppl. A):129A-134A
20. Sonnenblick EH, Fein F, Capasso JM, Factor SM: Microvascular spasm as a cause of cardiomyopathies and the calcium blocking agent verapamil as potential primary therapy. Am J Cardiol 1985;55:179B-184B
21. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH: Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982;66:342-354
22. Factor SM, Cho S: Alpha adrenergic blockade of the cardiomyopathic Syrian hamster: further evidence for the microvascular etiology of micronecrosis. Abstract. Fed Proc 1983;42:920
23. Gertz EW: Cardiomyopathic Syrian hamster: a possible model of human disease. Prog Exp Tumor Res 1972;16: 242-260
24. Strobeck JE, Factor SM, Bhan A, Sole M, Liew C, Fein F, Sonnenblick EH: hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical and structural features. Ann NY Acad Sci 1979;317:58-88
25. Forman R, Parmley WW, Sonnenblick EH: Myocardial contractility in relation to hypertrophy and failure in myopathie Syrian hamsters. J Mol Cell Cardiol 1972;4:203-211
26. Nakamura F, Nagano M, Kobayashi R, Higaki J, Mikami H, Kawaguchi N, Onishi S, Ogihara T: Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters. Am J Physiol 1994;267: H2297-H2304
27. Crespo MJ, Escobales N, Altieri PI: Endothelial dysfunction and enhanced contractility to angiotensin II in aortic rings from young cardiomyopathic hamsters. J Heart Failure 1995;2:Abstract 72
28. Cushman DW, Cheung HS: Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 1971;250:261-265
29. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, Michel JB: ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994;267:H1777-H1784
30. Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77(suppl. I):13-14
31. Conway RS, Factor SM, Sonnenblick EH, Baez S: Microvascular reactivity of the myopathic Syrian hamster cremaster muscle. Cardiovasc Res 1987;21:796-803
32. Crespo MJ, Escobales N, Altieri PI, Quidlgley J: Heart failure in the cardiomyopathic hamster model: possible role of angiotensin II. J Mol Cell Cardiol 1997;29(5): A53
33. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-482
34. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990;86: 1913-1920
35. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR: Endothelial function in congestive heart failure. Am Heart J 1993;126:761-764
36. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22(suppl. 4):S1-S14
37. Mayhan WG, Rubinstein I: Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem Biophys Res Commun 1992;184:1372-1377
38. Hirooka Y, Egashisa K, Imaizumi T, Tagawa T, Kai H: Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658-668
39. Rubanyi GM: Endothelium-derived vasoconstrictor factors: an overview. In Ryan US, Rubanyi GM: Endothelial regulation of vascular tone. Ch. 22. Marcel Dekker, New York, 1992, pp. 375-386